Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- Korai 1. fázisTaking peopleSafety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
- Where
- Chengdu
- Életkor
- 12 hónap and over
- People
- 10
- Run by
- Sichuan University
See details and how to joinNCT07067346 - Korai 1. fázisNot yet taking people in KínaGSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
- Where
- Beijing
- Életkor
- 6 év to 12 év
- People
- 10
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07090538 - 2. fázisNot yet taking people in KínaEfficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML
- Where
- Shanghai
- Életkor
- 14 év to 70 év
- People
- 44
- Run by
- Ruijin Hospital
See details and how to joinNCT07091006 - 2. fázisTaking peopleReduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 40
- Run by
- Peking University People's Hospital
See details and how to joinNCT06984536 - No phaseTaking peopleA Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach
- Where
- Beijing
- Életkor
- 3 év to 75 év
- People
- 100
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07066475 - No phaseTaking peopleClinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
- Where
- Nanjing
- Életkor
- Up to 18 év
- People
- 150
- Run by
- Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07064746 - 1/2. fázisTaking peopleCD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
- Where
- Guangzhou
- Életkor
- 14 év to 80 év
- People
- 30
- Run by
- Zhujiang Hospital
See details and how to joinNCT07072494 - No phaseTaking peopleJY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
- Where
- Kunming
- Életkor
- 2 év to 75 év
- People
- 36
- Run by
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
See details and how to joinNCT07065279 - No phaseNot yet taking people in KínaHuman-AI Collaborative INSIGHT Diagnostic Workflow for in Breast Cancer With Extensive Intraductal Component
- Where
- Guangzhou
- People
- 480
- Run by
- Sun Yat-sen University
See details and how to joinNCT07060599 - 1/2. fázisTaking peopleCRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
- Where
- Beijing
- Életkor
- 16 év to 85 év
- People
- 90
- Run by
- AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
See details and how to joinNCT07053462 - 1/2. fázisTaking peopleCRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
- Where
- Beijing
- Életkor
- 16 év to 85 év
- People
- 90
- Run by
- AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
See details and how to joinNCT07053488 - No phaseTaking peopleBladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
- Where
- Guangzhou
- People
- 480
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07051083 - No phaseTaking peopleMulti-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
- Where
- Suzhou
- People
- 150
- Run by
- Zhao Jun
See details and how to joinNCT07047573 - No phaseCsak meghívásosExplainable Machine Learning for Predicting Early Gastric Cancer
- Where
- Wenzhou
- People
- 10
- Run by
- Wenzhou Central Hospital
See details and how to joinNCT07047937 - No phaseNot yet taking people in KínaEvaluating AI and Human Expert Decisions in Colorectal Cancer
- Where
- Beijing
- People
- 1500
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07045207 - No phaseTaking peopleMSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
- Where
- Shanghai
- People
- 1000
- Run by
- Yingbin Liu, MD, PhD, FACS
See details and how to joinNCT07045571 - Korai 1. fázisTaking peopleTargeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
- Where
- Shanghai
- Életkor
- 6 hónap and over
- People
- 2
- Run by
- Eye & ENT Hospital of Fudan University
See details and how to joinNCT06424301 - 3. fázisNot yet taking people in KínaOlanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
- Where
- Shanghai
- Életkor
- 5 év to 18 év
- People
- 100
- Run by
- Shanghai Children's Medical Center
See details and how to joinNCT07035821 - 1/2. fázisTaking peopleClinical Study of U32 in Patients With Acute Myeloid Leukemia
- Where
- Suzhou
- Életkor
- 2 év to 65 év
- People
- 20
- Run by
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
See details and how to joinNCT07036250 - No phaseTaking peopleThe Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
- Where
- Taiyuan
- Életkor
- 14 év to 75 év
- People
- 50
- Run by
- Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT05618041 - No phaseTaking peopleLong-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
- Where
- Beijing, Tianjin, Wuhan, Zhengzhou
- People
- 1500
- Run by
- Nanjing IASO Biotechnology Co., Ltd.
See details and how to joinNCT07028970 - No phaseTaking peopleNoninvasive Intratumor Heterogeneity Evaluation in HNSCC
- Where
- Chongqing
- Életkor
- 15 év to 89 év
- People
- 700
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07027280 - 2. fázisTaking peopleClinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
- Where
- Guangzhou
- Életkor
- 12 hónap and over
- People
- 120
- Run by
- Sun Yat-Sen University Cancer Center
See details and how to joinNCT06013618 - No phaseTaking peopleNational Longitudinal Cohort of Hematological Diseases (NICHE) - CART
- Where
- Tianjin
- People
- 1000
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06607289 - Korai 1. fázisCsak meghívásosThe Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
- Where
- Wuxi
- Életkor
- 15 év to 75 év
- People
- 20
- Run by
- Affiliated Hospital of Jiangnan University
See details and how to joinNCT07023861